Tritanopia is an extremely rare form of color blindness characterized by a selective deficiency of blue vision.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation on blue color blindness is limited primarily due to its extreme rarity, affecting fewer than 10 individuals per 100,000. This rarity leads to a lack of systematic clinical studies and comprehensive phenotypic characterization. Additionally, the genetic basis was only recently identified, and ongoing research is required to better understand the clinical features and implications of this condition.
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in hereditary vision disorders. They can provide insights into managing your symptoms and any potential interventions. Additionally, genetic counseling is recommended to understand the implications of the OPN1SW gene variant for you and your family. For further resources, you can visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which may provide additional guidance and information on related conditions.
Currently, there is one active clinical trial related to blue color blindness. You can explore more about this trial and its details by visiting ClinicalTrials.gov. While there are no orphan drugs designated for this condition, the existence of clinical trials offers hope for future treatment options and a better understanding of the condition.
Actionable guidance for navigating care for blue color blindness
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in hereditary vision disorders. They can provide insights into managing your symptoms and any potential interventions. Additionally, genetic counseling is recommended to understand the implications of the OPN1SW gene variant for you and your family. For further resources, you can visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which may provide additional guidance and information on related conditions.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on blue color blindness is limited primarily due to its extreme rarity, affecting fewer than 10 individuals per 100,000. This rarity leads to a lack of systematic clinical studies and comprehensive phenotypic characterization. Additionally, the genetic basis was only recently identified, and ongoing research is required to better understand the clinical features and implications of this condition.
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in hereditary vision disorders. They can provide insights into managing your symptoms and any potential interventions. Additionally, genetic counseling is recommended to understand the implications of the OPN1SW gene variant for you and your family. For further resources, you can visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which may provide additional guidance and information on related conditions.
Currently, there is one active clinical trial related to blue color blindness. You can explore more about this trial and its details by visiting ClinicalTrials.gov. While there are no orphan drugs designated for this condition, the existence of clinical trials offers hope for future treatment options and a better understanding of the condition.
Actionable guidance for navigating care for blue color blindness
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in hereditary vision disorders. They can provide insights into managing your symptoms and any potential interventions. Additionally, genetic counseling is recommended to understand the implications of the OPN1SW gene variant for you and your family. For further resources, you can visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which may provide additional guidance and information on related conditions.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on blue color blindness is limited primarily due to its extreme rarity, affecting fewer than 10 individuals per 100,000. This rarity leads to a lack of systematic clinical studies and comprehensive phenotypic characterization. Additionally, the genetic basis was only recently identified, and ongoing research is required to better understand the clinical features and implications of this condition.
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in hereditary vision disorders. They can provide insights into managing your symptoms and any potential interventions. Additionally, genetic counseling is recommended to understand the implications of the OPN1SW gene variant for you and your family. For further resources, you can visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which may provide additional guidance and information on related conditions.
Currently, there is one active clinical trial related to blue color blindness. You can explore more about this trial and its details by visiting ClinicalTrials.gov. While there are no orphan drugs designated for this condition, the existence of clinical trials offers hope for future treatment options and a better understanding of the condition.
Actionable guidance for navigating care for blue color blindness
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in hereditary vision disorders. They can provide insights into managing your symptoms and any potential interventions. Additionally, genetic counseling is recommended to understand the implications of the OPN1SW gene variant for you and your family. For further resources, you can visit the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov, which may provide additional guidance and information on related conditions.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.